Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Huard

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Current Opinion in Immunology|August 19, 2021
The number 13 of the family: a proliferation inducing ligandLaurie Baert, Mashal Claude Ahmed, Benoit Manfroi, et al.
Trends in Immunology|October 20, 2009
Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destructionEmmanuel Contassot, Olivier Preynat-Seauve, Lars French, et al.
Glycobiology|March 8, 2021
Further analyses of APRIL/APRIL-receptor/glycosaminoglycan interactions by biochemical assays linked to computational studiesMateusz Marcisz, Bertrand Huard, Agnieszka G Lipska, et al.
Biomolecules|September 28, 2021
Advanced Molecular Dynamics Approaches to Model a Tertiary Complex APRIL/TACI with Long GlycosaminoglycansMateusz Marcisz, Martyna Maszota-Zieleniak, Bertrand Huard, et al.
International Reviews of Immunology|February 21, 2017
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseasesEileen Samy, Stephen Wax, Bertrand Huard, et al.
Journal of Autoimmunity|November 3, 2018
The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targetingLaurie Baert, Benoit Manfroi, Olivier Casez, et al.
Trends in Immunology|September 11, 2007
HLA and KIR polymorphisms affect NK-cell anti-tumor activityJakob R Passweg, Bertrand Huard, Jean-Marie Tiercy, et al.
European Journal of Immunology|November 19, 2004
Expression of inhibitory KIR is confined to CD8+ effector T cells and limits their proliferative capacityLionel Arlettaz, Sylvie Degermann, Casimir De Rham, et al.
Melanoma Research|May 17, 2007
Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cellsOlivier Preynat-Seauve, Emmanuel Contassot, Prisca Schuler, et al.
Experimental Hematology|April 29, 2008
Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 casesPhilip Went, Alexander Tzankov, Juerg Schwaller, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Current Opinion in Immunology|August 19, 2021
The number 13 of the family: a proliferation inducing ligandLaurie Baert, Mashal Claude Ahmed, Benoit Manfroi, et al.
Trends in Immunology|October 20, 2009
Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destructionEmmanuel Contassot, Olivier Preynat-Seauve, Lars French, et al.
Glycobiology|March 8, 2021
Further analyses of APRIL/APRIL-receptor/glycosaminoglycan interactions by biochemical assays linked to computational studiesMateusz Marcisz, Bertrand Huard, Agnieszka G Lipska, et al.
Biomolecules|September 28, 2021
Advanced Molecular Dynamics Approaches to Model a Tertiary Complex APRIL/TACI with Long GlycosaminoglycansMateusz Marcisz, Martyna Maszota-Zieleniak, Bertrand Huard, et al.
International Reviews of Immunology|February 21, 2017
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseasesEileen Samy, Stephen Wax, Bertrand Huard, et al.
Journal of Autoimmunity|November 3, 2018
The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targetingLaurie Baert, Benoit Manfroi, Olivier Casez, et al.
Trends in Immunology|September 11, 2007
HLA and KIR polymorphisms affect NK-cell anti-tumor activityJakob R Passweg, Bertrand Huard, Jean-Marie Tiercy, et al.
European Journal of Immunology|November 19, 2004
Expression of inhibitory KIR is confined to CD8+ effector T cells and limits their proliferative capacityLionel Arlettaz, Sylvie Degermann, Casimir De Rham, et al.
Melanoma Research|May 17, 2007
Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cellsOlivier Preynat-Seauve, Emmanuel Contassot, Prisca Schuler, et al.
Experimental Hematology|April 29, 2008
Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 casesPhilip Went, Alexander Tzankov, Juerg Schwaller, et al.
Pageof 6